Your browser doesn't support javascript.
loading
D-2-Hydroxyglutarate Is Necessary and Sufficient for Isocitrate Dehydrogenase 1 Mutant-Induced MIR148A Promoter Methylation.
Li, Tie; Cox, Christopher D; Ozer, Byram H; Nguyen, Nhung T; Nguyen, HuyTram N; Lai, Thomas J; Li, Sichen; Liu, Fei; Kornblum, Harley I; Liau, Linda M; Nghiemphu, Phioanh L; Cloughesy, Timothy F; Lai, Albert.
Afiliação
  • Li T; Neuro-Oncology Program, Department of Neurology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.
  • Cox CD; Neuro-Oncology Program, Department of Neurology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.
  • Ozer BH; Neuro-Oncology Program, Department of Neurology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.
  • Nguyen NT; Neuro-Oncology Program, Department of Neurology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.
  • Nguyen HN; Neuro-Oncology Program, Department of Neurology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.
  • Lai TJ; Neuro-Oncology Program, Department of Neurology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.
  • Li S; Neuro-Oncology Program, Department of Neurology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.
  • Liu F; Neuro-Oncology Program, Department of Neurology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.
  • Kornblum HI; Department of Pediatrics, Psychiatry and Biobehavioral Sciences, Pediatric Neurology, Semel Institute for Neuroscience and Human Behavior, Molecular & Medical Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.
  • Liau LM; Department of Neurosurgery, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.
  • Nghiemphu PL; Neuro-Oncology Program, Department of Neurology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.
  • Cloughesy TF; Neuro-Oncology Program, Department of Neurology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.
  • Lai A; Neuro-Oncology Program, Department of Neurology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California. albertlai@mednet.ucla.edu.
Mol Cancer Res ; 16(6): 947-960, 2018 06.
Article em En | MEDLINE | ID: mdl-29545476

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Metilação de DNA / MicroRNAs / Glutaratos / Isocitrato Desidrogenase Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Metilação de DNA / MicroRNAs / Glutaratos / Isocitrato Desidrogenase Idioma: En Ano de publicação: 2018 Tipo de documento: Article